Industry leaders argue that by permitting imports of refurbished devices, the policy undermines India’s self-reliance in medical manufacturing and negatively impacts domestic manufacturers
Read MoreSpeaking at the 21st Indo-US Economic Summit organised by the Indo-American Chamber of Commerce (IACC), Bhagat emphasised the need for the private sector to move beyond commercial interests in healthcare
Read MoreThe non-exclusive patent license agreement allows Mankind Pharma to commercialise Vonoprazan, a potassium-competitive acid blocker (P-CAB), for the treatment of Gastroesophageal Reflux Disease (GERD) and other acid-related disorders
Read MoreThe company's mission focuses on reducing avoidable blindness in India by developing affordable and portable ophthalmic screening devices
Read More